1 / 20

QREs: A Subset of Biological Product Deviation Reports

QREs: A Subset of Biological Product Deviation Reports. Sharon O’Callaghan CBER Office of Compliance and Biologics Quality Division of Inspections and Surveillance. Public Workshop: Quarantine Release Errors September 13, 2011. Agenda. Overview of BPD Reports BPDs identified as QREs

connie
Download Presentation

QREs: A Subset of Biological Product Deviation Reports

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. QREs: A Subset of Biological Product Deviation Reports Sharon O’Callaghan CBER Office of Compliance and Biologics Quality Division of Inspections and Surveillance Public Workshop: Quarantine Release Errors September 13, 2011

  2. Agenda • Overview of BPD Reports • BPDs identified as QREs • Contributing Factors Sharon O'Callaghan

  3. Biological Product Deviation (BPD) Data • BPD Reports received between Oct. 1, 2005 and Sept. 30, 2010 (FY06-FY10) • Type of Establishments • Licensed Blood Establishment • Unlicensed Registered Blood Establishments • Transfusion Services Sharon O'Callaghan

  4. BPD Reports Received FY06-FY10All Blood Establishments Sharon O'Callaghan

  5. Quarantine Release Errors (QREs) • Information known PRIOR to distribution of product that warrants quarantine; product subsequently distributed • BPDs not included: • Post Donation Information • Labeling • Routine Testing (ABO, Rh, antibody, antigen) • Miscellaneous – seroconversions, possible transfusion transmitted disease Sharon O'Callaghan

  6. BPD Reports Received FY06-FY10All Blood Establishments Sharon O'Callaghan

  7. BPD Reports Received FY06-FY10Licensed Blood Establishments Total BPDRs (133,164) includes Labeling, Miscellaneous, Post Donation and Routine Testing - not shown Sharon O'Callaghan

  8. BPD Reports Received FY06-FY10Unlicensed Registered Blood Establishments Total BPDRs (19,431) includes Labeling, Miscellaneous, Post Donation and Routine Testing - not shown Sharon O'Callaghan

  9. BPD Reports Received FY06-FY10Transfusion Services Total BPDRs (8,857) includes Labeling and Routine Testing - not shown Sharon O'Callaghan

  10. Blood Collection BC41** Sterility compromised Air contamination; Arm prep not performed or performed inappropriately BC42** Collection bag Blood drawn into outdated bag; Incorrect collection bag used BC43** Collection process Collection time extended, discrepant, or not documented; not discovered prior to component preparation; Overbleed; not discovered prior to component preparation Sharon O'Callaghan

  11. Component Preparation CP-51-** Sterility compromised Air contamination CP-52-** Component not prepared in accordance with specifications Platelets made from WB-donor took medication that may affect platelet function; Resting time requirements not met for Platelets; Platelets not agitated; Platelet count/yield not acceptable; Processed at incorrect centrifuge setting; Product not frozen within the appropriate time frame; Product prepared or held at incorrect temperature; Components not prepared within appropriate time frame after collection; Additive solution not added, added incorrectly, or added to incorrect product or expired additive solution CP-53-** Component prepared from Whole Blood unit that was Overweight; Underweight; Collected or stored at unacceptable or undocumented temperature; A difficult collection or had an extended collection time CP-54-** Component manufactured that was Overweight; Underweight Sharon O'Callaghan

  12. Donor Deferral Donor missing or incorrectly identified on deferral list, donor was or should have been previously deferred DD-31** due to testing DD-32** due to history Donor incorrectly deleted from deferral list or donor not reentered properly, donor previously deferred DD-34** due to testing DD-35** due to history Sharon O'Callaghan

  13. Donor Screening DS21** Donor did not meet acceptance criteria; temperature, medical review or physical DS2203 Donor history record incomplete or incorrect-donor history questions DS23-25 Deferral screening not done or incorrectly performed; donor not deferred; deferred due to testing or history DS27/ 28 Incorrect ID used during deferral search donor deferred due to testing or history DS-29** Donor gave history which warranted deferral, donor not deferred

  14. Testing VT71** Testing performed, interpreted or documented incorrectly VT72** Sample identification QC92** QC & Distribution; Positive testing QC93** QC & Distribution; Testing not performed, incompletely performed or not documented Note: Testing includes HIV, HBV, HCV, HTLV, Syphilis Sharon O'Callaghan

  15. Quality Control & Distribution QC91** Failure to quarantine unit due to medical history QC9402/04 Distribution of product that did not meet specifications Outdated product; Product QC unacceptable QC9412-17 Failure to quarantine due to collection, component prep, donor screening, donor deferral, shipping or storage deviation/unexpected event QC96** Shipping and storage stored at incorrect temperature; product returned and reissued inappropriately (includes QC-97-18)

  16. Contributing Factors Licensed Blood Establishments Sharon O'Callaghan

  17. Contributing FactorsUnlicensed Registered Blood Establishments Sharon O'Callaghan

  18. Contributing FactorsTransfusion Services Sharon O'Callaghan

  19. Closing Thoughts • BPD Data has value • For FDA - for public health planning and regulatory focus • For Industry - identify issues and track effectiveness of corrective actions • Based on BPD Data, most QREs result from human errors/process controls Sharon O'Callaghan

  20. QUESTIONS????

More Related